Maximum quantity allowed is 999
CAS RN: 23076-35-9 | Product Number: X0059
Xylazine Hydrochloride
Purity: >98.0%(T)(HPLC)
- N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine Hydrochloride
- 2-[(2,6-Dimethylphenyl)amino]-5,6-dihydro-4H-1,3-thiazine Hydrochloride
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
5G |
₹7,400.00
|
3 | ≥40 |
|
25G |
₹18,100.00
|
1 | 7 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | X0059 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__2H__1__6N__2S·HCl = 256.79 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 23076-35-9 |
Related CAS RN | 7361-61-7 |
Reaxys Registry Number | 6448471 |
PubChem Substance ID | 87577918 |
Merck Index (14) | 10080 |
MDL Number | MFCD00058196 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Solubility in Water | almost transparency |
Pictogram | |
Signal Word | Danger |
Hazard Statements | H301 : Toxic if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
RTECS# | XJ0776350 |
UN Number | UN2811 |
Class | 6.1 |
Packing Group | III |
References
- 1) Xylazine - a review of its pharmacology and use in veterinary medicine
- 2) Alpha2 adrenoceptor agonists in the horse – a review
- 3) Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis
- 4) Re-evaluation of the pharmacokinetics of xylazine administered to Thoroughbred horses
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.